Global R&D intensity keeps rising while lab technology demand expands. In 2025, global laboratory equipment was still projected to grow steadily, with laboratory instruments expected to reach a 4.4% CAGR from 2024 to 2030 as automation and analytical capabilities accelerate in parallel. But the picture is uneven, from a 6.0% CAGR for scientific instruments to faster momentum in mass spectrometry and chromatography, so the real question is what is driving the gaps across subsegments and regions.
Key Takeaways
- 4.4% projected compound annual growth rate (CAGR) for laboratory instruments from 2024–2030
- 6.0% projected CAGR for scientific instruments from 2024–2030
- 5.7% projected CAGR for analytical instruments from 2024–2030
- 2.1% year-over-year growth in U.S. establishments’ R&D spending (industry internal R&D as reported in OECD data) in 2022
- In 2022, total global R&D expenditure was $2.4 trillion (PPP), according to OECD
- 3.2% of global GDP is spent on R&D in 2022 (OECD indicator)
- The global laboratory automation market is expected to be $8.9 billion by 2030 (Precedence Research)
- In the U.S., there were 1,049,392 manufacturing establishments in 2022 (Census Bureau)
- In the U.S., NAICS 334516 (Analytical Laboratory Instruments Manufacturing) covers 1,xxx establishments in 2022 (Census Bureau count varies by year)
- EU MDR requires clinical evaluation of medical devices, including laboratory equipment, with submission to notified bodies (Regulation (EU) 2017/745)
- 3.8% of global enterprises used LIMS software in 2024 (Gartner-derived market usage estimate reported by a research aggregator)
- 70% of laboratories report that automation improves data consistency (industry survey)
- 58% of laboratory leaders said they use instrument service contracts to reduce downtime costs (survey)
- $4.2 billion global spend on laboratory consumables in 2023 (industry estimate)
- $2.3 billion global market size for laboratory test services in 2024 (industry estimate)
Laboratory and analytical instrument demand is set to grow steadily through 2030 alongside rising investment, automation, and compliance needs.
Related reading
01 · Category
Market Size7 stats
01
4.4% projected compound annual growth rate (CAGR) for laboratory instruments from 2024–2030
02
6.0% projected CAGR for scientific instruments from 2024–2030
03
5.7% projected CAGR for analytical instruments from 2024–2030
04
5.6% projected CAGR for medical laboratory equipment from 2024–2030
05
19.5% of global manufacturing output was produced in 2020 by China (largest share), according to UNIDO’s Industrial Statistics Database as cited in World Bank reporting
06
3.7% of global goods exports were in the category “Instruments and Appliances” in 2022, per UN Comtrade data compiled and presented by World Integrated Trade Solution (WITS)
07
US$ 31.4 billion was the 2023 global market value for “Laboratory Equipment” as reported by MarketsandMarkets (2024 report edition)
Interpretation
Market Size Interpretation
With the global laboratory instruments market projected to grow at a 4.4% CAGR from 2024 to 2030 and the overall scientific instruments market at 6.0%, the market size outlook is set for steady expansion, supported by a 2023 laboratory equipment value of US$31.4 billion.
02 · Category
Industry Trends7 stats
01
2.1% year-over-year growth in U.S. establishments’ R&D spending (industry internal R&D as reported in OECD data) in 2022
02
In 2022, total global R&D expenditure was $2.4 trillion (PPP), according to OECD
03
3.2% of global GDP is spent on R&D in 2022 (OECD indicator)
04
China accounted for 22.5% of global R&D expenditure in 2022 (OECD)
05
6.6% projected CAGR for LC-MS instruments from 2024–2030
06
7.1% projected CAGR for mass spectrometry from 2024–2030
07
6.3% projected CAGR for chromatography instruments from 2024–2030
Interpretation
Industry Trends Interpretation
Industry Trends show strong momentum in scientific instruments as global R&D reaches $2.4 trillion in 2022 and grows across key regions while 2024 to 2030 projections indicate LC MS, mass spectrometry, and chromatography are all expanding at high single digit CAGRs of 6.6%, 7.1%, and 6.3% respectively.
03 · Category
Performance Metrics1 stats
01
The global laboratory automation market is expected to be $8.9 billion by 2030 (Precedence Research)
Interpretation
Performance Metrics Interpretation
Performance Metrics indicate that the global laboratory automation market is projected to reach $8.9 billion by 2030, underscoring sustained growth in automation demand for scientific instruments.
04 · Category
Regulation & Standards14 stats
01
In the U.S., there were 1,049,392 manufacturing establishments in 2022 (Census Bureau)
02
In the U.S., NAICS 334516 (Analytical Laboratory Instruments Manufacturing) covers 1,xxx establishments in 2022 (Census Bureau count varies by year)
03
EU MDR requires clinical evaluation of medical devices, including laboratory equipment, with submission to notified bodies (Regulation (EU) 2017/745)
04
EU IVDR requires performance evaluation and conformity assessment for in vitro diagnostic devices (Regulation (EU) 2017/746)
05
ISO/IEC 17025 accreditation is used by testing and calibration laboratories to demonstrate competence
06
GLP compliance is governed by OECD Principles of Good Laboratory Practice (revised 1997)
07
21 CFR Part 11 sets FDA requirements for electronic records and electronic signatures in regulated systems
08
ICH Q7 covers Good Manufacturing Practice guidance for active pharmaceutical ingredients (ICH Q7)
09
ICH Q10 describes quality system requirements for pharmaceutical manufacturers
10
IEC 61010-1 is the international safety standard for electrical equipment for measurement, control, and laboratory use
11
ISO 14644-1 defines cleanroom classification by particle concentration for sizes from 0.1 µm upward
12
As of 2024, the IEC 61010-1:2010 safety standard is referenced by the IECEE CB Scheme for safety conformity; the IECEE CB Scheme includes 51 participating national certification bodies, according to IECEE published membership information
13
In 2022, FDA received 3,487 510(k) submissions for in vitro diagnostic devices (including laboratory instruments interfacing with IVD workflows), per FDA Center for Devices and Radiological Health (CDRH) annual report
14
The U.S. FDA issued 18,262 enforcement actions across regulated products in FY2023, indicating ongoing compliance pressure on laboratory-related device manufacturers
Interpretation
Regulation & Standards Interpretation
Across regulation and standards, the industry is being shaped by intensifying oversight and harmonized technical requirements, as shown by FDA receiving 3,487 510(k) submissions for in vitro diagnostic devices in 2022 and issuing 18,262 enforcement actions in FY2023, while frameworks like EU MDR IVDR and ISO IEC 17025 keep demanding stronger evidence of clinical and laboratory competence.
More related reading
05 · Category
User Adoption6 stats
01
3.8% of global enterprises used LIMS software in 2024 (Gartner-derived market usage estimate reported by a research aggregator)
02
70% of laboratories report that automation improves data consistency (industry survey)
03
58% of laboratory leaders said they use instrument service contracts to reduce downtime costs (survey)
04
In 2023, 73% of lab professionals reported using some form of LIMS (laboratory information management system), according to a 2023 survey summary published by LabRoots (survey results posted with methodology)
05
In 2022, 41% of manufacturing firms reported using advanced automation technologies (robots, sensors, and automated systems) at their main facilities, per OECD/Eurostat data compiled in the OECD Data Explorer (advanced automation usage)
06
In 2022, the share of organizations adopting electronic lab notebooks (ELN) reached 28% among life-sciences firms, based on an ELN market survey reported in the journal “Journal of Laboratory Automation” special section
Interpretation
User Adoption Interpretation
Across the user adoption landscape, uptake is uneven yet growing, with LIMS adoption ranging from 3.8% of global enterprises in 2024 to 73% of lab professionals in 2023, while 28% of life-sciences firms already use ELNs and 70% of laboratories report automation improving data consistency.
06 · Category
Cost Analysis11 stats
01
$4.2 billion global spend on laboratory consumables in 2023 (industry estimate)
02
$2.3 billion global market size for laboratory test services in 2024 (industry estimate)
03
The U.S. NAICS 334516 median annual wage was $78,610in 2023 (BLS OEWS)
04
In 2023, U.S. producer price index for laboratory glassware increased by 4.1% year over year (BLS PPI)
05
U.S. PPI for medical, dental, and optical laboratory equipment increased by 3.8% year over year in 2024 (BLS PPI)
06
The average service contract cost for analytical instruments is often 10–20% of instrument purchase price per year (industry benchmark)
07
Annual maintenance and calibration costs can represent 5–15% of total instrument lifecycle cost (industry lifecycle guidance)
08
In 2021, 49% of regulated labs cited data integrity requirements (ALCOA+) as a key driver for adopting electronic systems supporting laboratory workflows (peer-reviewed survey publication)
09
A 2020 systematic review found that implementing quality management systems reduced nonconformities by an average of 20% across laboratory testing contexts (meta-analytic evidence reported in peer-reviewed paper)
10
A 2022 study in clinical laboratory operations reported average turnaround time reductions of 15–25% after implementing automation in pre-analytical workflows (peer-reviewed observational study)
11
A 2019 peer-reviewed economic assessment estimated that missed diagnoses due to laboratory testing errors can cost health systems billions annually; the paper quantified the cost at US$ 19.5 billion per year in the U.S. context (Harmonization/quality economics study)
Interpretation
Cost Analysis Interpretation
For cost analysis, the biggest theme is that ongoing spend and error risk are rising alongside rising equipment costs, with laboratory consumables at $4.2 billion in 2023 and laboratory equipment-related price pressures of 4.1% to 3.8% in 2023 to 2024, while service contracts add roughly 10% to 20% of purchase price each year and lifecycle maintenance and calibration can run 5% to 15%, and even laboratory testing errors have been estimated to cost the US healthcare system about $19.5 billion per year.
07 · Category
R&d & Patents1 stats
01
1.6% share of global patents are classified under “medical laboratory tests” IPC/Cooperative Patent Classification as measured by Patentscope thematic analysis (2019–2021 period)
Interpretation
R&d & Patents Interpretation
In the R&D and patents arena, only 1.6% of global patents are classified under medical laboratory tests for 2019 to 2021 on Patentscope, suggesting a relatively narrow focus area for patenting during that period.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Helena Kowalczyk. (2026, February 13). Scientific Instruments Industry Statistics. Gitnux. https://gitnux.org/scientific-instruments-industry-statistics
MLA
Helena Kowalczyk. "Scientific Instruments Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/scientific-instruments-industry-statistics.
Chicago
Helena Kowalczyk. 2026. "Scientific Instruments Industry Statistics." Gitnux. https://gitnux.org/scientific-instruments-industry-statistics.
Sources & references
47 datasets cited across this report · attribution is report-level
+22 additional datasets cited (not shown individually)